Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0G79 market cap is 14.58B. The company's latest EPS is SEK 0.2404 and P/E is 1455.91.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 46.53M | 49.4M | 59.18M | 68.53M | 89.21M |
| Operating Income | 4.7M | 3.57M | 8.27M | 4.77M | 14.08M |
| Net Income | 3.73M | 663k | 7.9M | 5.88M | 10.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 56.44M | 47.82M | 60.85M | 127.43M | 142.97M |
| Total Liabilities | 12.65M | 9.64M | 14.71M | 20.31M | 26.39M |
| Total Equity | 43.79M | 38.18M | 46.13M | 107.13M | 116.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 12.77M | -8.93M | 4.35M | -15.24M | -6.96M |
| Investing | -3.62M | -5.56M | -5.22M | -10.5M | -9.72M |
| Financing | -6.55M | -7.04M | -957k | 53.68M | -1.01M |
| Market Cap | 14.58B |
| Price to Earnings Ratio | 1455.91 |
| Price to Sales Ratio | 163.41 |
| Price to Cash Ratio | 683.73 |
| Price to Book Ratio | 125.05 |
| Dividend Yield | - |
| Shares Outstanding | 41.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 350.00 |
| 52 Week Low | 350.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Syntheticmr Ab (publ) |
| Address |
grev turegatan 11c stockholm SE-114 46 |
| Website | https://www.syntheticmr.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
